ZARODEX THERAPEUTICS LTD has a total of 21 patent applications. Its first patent ever was published in 2018. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals are 45 SEC LLC, HUBRECHT LAB and ORAMED LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | China | 3 | |
#4 | Australia | 2 | |
#5 | Canada | 2 | |
#6 | United Kingdom | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Singapore | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Mchale Duncan | 18 |
#2 | Ashrafian Houman | 18 |
#3 | Jolles Stephen | 18 |
Publication | Filing date | Title |
---|---|---|
GB202101280D0 | Novel compounds | |
GB201910873D0 | Novel uses | |
EP3746084A1 | Clozapine for the treatment of ig-e driven b cell diseases | |
AU2019216380A1 | Clozapine for the treatment of a immunoglobulin driven B cell disease | |
EP3520803A1 | Novel uses |